Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 34.08%443.19B | 19.27%1.44T | 9.34%330.54B | 26.49%1.21T | 14.08%345.79B | 40.92%289.89B | 19.76%272.52B | 37.04%302.31B | 25.32%956.98B | 28.34%303.1B |
| Cost of revenue | 35.16%188.98B | 9.90%609.62B | 10.47%139.83B | 44.55%554.69B | 44.82%170.76B | 49.50%132.05B | 37.22%125.31B | 46.86%126.57B | 45.37%383.74B | 36.62%117.92B |
| Gross profit | 33.29%254.21B | 27.19%834.12B | 8.52%190.72B | 14.41%655.82B | -5.49%175.02B | 34.46%157.85B | 8.06%147.21B | 30.74%175.74B | 14.73%573.24B | 23.57%185.18B |
| Operating expense | 1.77%141.09B | 4.44%541.56B | 6.66%138.63B | 13.44%518.52B | 3.71%134.96B | 9.65%130.33B | 17.74%123.24B | 25.71%129.98B | 38.79%457.08B | 50.42%130.14B |
| Selling and administrative expenses | 14.58%120.99B | 8.85%441.66B | 6.76%105.59B | 11.69%405.76B | 7.38%321.13B | 5.10%27.7B | 12.43%97.39B | 18.34%98.9B | 58.07%363.3B | 234.94%299.06B |
| -General and administrative expense | 14.58%120.99B | 8.85%441.66B | 6.76%105.59B | 11.69%405.76B | 7.38%321.13B | 5.10%27.7B | 12.43%97.39B | 18.34%98.9B | 58.07%363.3B | 234.94%299.06B |
| Other operating expenses | -39.16%20.1B | -11.41%99.9B | 6.32%33.04B | 20.24%112.77B | -10.20%-186.16B | 10.94%102.63B | 43.20%25.86B | 56.77%31.08B | -5.74%93.78B | -5,991.71%-168.92B |
| Operating profit | 117.18%113.11B | 113.09%292.55B | 13.83%52.08B | 18.19%137.29B | -27.23%40.06B | 1,972.84%27.51B | -24.06%23.97B | 47.49%45.76B | -31.80%116.16B | -13.11%55.05B |
| Net non-operating interest income (expenses) | ||||||||||
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 646.17%5.46B | 103.09%29.47B | -81.60%732M | 127.62%14.51B | 10.92%4.05B | 310.28%4.43B | 609.34%2.05B | 194.09%3.98B | -6.54%6.38B | 593.78%3.65B |
| Special income (charges) | 85.06%322M | -77.93%623M | -42.00%174M | 14.76%2.82B | 404.84%2.5B | 0 | 19M | 300M | -99.07%2.46B | 433.33%496M |
| Less:Restructuring and mergern&acquisition | -85.06%-322M | 77.93%-623M | 42.00%-174M | -14.76%-2.82B | -404.84%-2.5B | --0 | ---19M | ---300M | 99.07%-2.46B | -433.33%-496M |
| Other non-operating income (expenses) | -2,202.02%-28.55B | -209.04%-40.36B | 82.35%-1.24B | 42.86%-13.06B | 18.27%-5.13B | 62.79%-2.1B | 153.30%1.2B | 19.21%-7.03B | 19.12%-22.86B | 62.99%-6.28B |
| Income before tax | 74.60%90.35B | 99.40%282.29B | 20.32%51.75B | 38.60%141.57B | -21.61%41.48B | 835.51%29.85B | -8.01%27.23B | 81.64%43.01B | -75.25%102.14B | 15.70%52.92B |
| Income tax | -37.02%8.38B | 233.17%93.13B | 23.81%13.31B | -8.18%27.95B | -111.03%-1.96B | 420.84%7.91B | 39.67%11.25B | 51.42%10.75B | -46.59%30.44B | -39.68%17.76B |
| Net income | 113.26%81.97B | 66.49%189.16B | 19.16%38.44B | 58.47%113.62B | 23.55%43.44B | 1,477.83%21.94B | -25.83%15.99B | 94.58%32.26B | -79.85%71.7B | 115.73%35.16B |
| Net income continuous operations | 113.26%81.97B | 66.49%189.16B | 19.16%38.44B | 58.47%113.62B | 23.55%43.44B | 1,477.83%21.94B | -25.83%15.99B | 94.58%32.26B | -79.85%71.7B | 115.73%35.16B |
| Noncontrolling interests | -115.45%-2.64B | 2.52%27.04B | 119.08%17.06B | -27.25%26.37B | 94.81%15.81B | 69.51%-593M | -69.64%3.36B | -59.00%7.79B | 425.71%36.25B | -36.57%8.12B |
| Net income attributable to the company | 295.87%84.61B | 85.83%162.12B | -12.65%21.37B | 146.14%87.24B | 2.16%27.63B | 6,281.87%22.53B | 20.54%12.62B | 1,111.03%24.47B | -90.34%35.45B | 672.41%27.04B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 295.87%84.61B | 85.83%162.12B | -12.65%21.37B | 146.14%87.24B | 2.16%27.63B | 6,281.87%22.53B | 20.54%12.62B | 1,111.03%24.47B | -90.34%35.45B | 672.41%27.04B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 294.41%139.6 | 69.42%268.045 | -21.20%35.395 | 136.37%158.215 | -3.25%49.265 | 6,193.85%40.91 | 18.88%23.11 | 1,010.23%44.92 | -91.07%66.935 | 632.66%50.92 |
| Diluted earnings per share | 270.79%130.48 | 79.51%256.335 | -10.29%35.19 | 141.34%142.8 | 2.55%45.515 | 5,711.63%37.485 | 20.06%20.615 | 894.83%39.225 | -90.80%59.17 | 630.62%44.385 |
| Dividend per share | 0 | 13.33%85 | 0 | 0.00%75 | 0.00%60 | 0 | 0.00%15 | 0 | 0.00%75 | 0.00%60 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |